James B Schneider1, Todd Sweberg, Lisa A Asaro, Aileen Kirby, David Wypij, Ravi R Thiagarajan, Martha A Q Curley. 1. 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Cohen Children's Medical Center, Hofstra-Northwell School of Medicine, New York, NY. 2Department of Cardiology, Boston Children's Hospital, Boston, MA. 3Division of Pediatric Critical Care Medicine, Oregon Health & Science University School of Medicine, Portland, OR. 4Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA. 5Department of Pediatrics, Harvard Medical School, Boston, MA. 6Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia, PA. 7Division of Anesthesia and Critical Care Medicine at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 8Critical Care and Cardiovascular Program, Boston Children's Hospital, Boston, MA.
Abstract
OBJECTIVES: To describe sedation management in children supported on extracorporeal membrane oxygenation for acute respiratory failure. DESIGN: Secondary analysis of prospectively collected data from a multicenter randomized trial of sedation (Randomized Evaluation of Sedation Titration for Respiratory Failure). SETTING: Twenty-one U.S. PICUs. PATIENTS: One thousand two hundred fifty-five children, 2 weeks to 17 years old, with moderate/severe pediatric acute respiratory distress syndrome. INTERVENTIONS: Sedation managed per usual care or Randomized Evaluation of Sedation Titration for Respiratory Failure protocol. MEASUREMENTS AND MAIN RESULTS: Sixty-one Randomized Evaluation of Sedation Titration for Respiratory Failure patients (5%) with moderate/severe pediatric acute respiratory distress syndrome were supported on extracorporeal membrane oxygenation, including 29 managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol. Most extracorporeal membrane oxygenation patients received neuromuscular blockade (46%) or were heavily sedated with State Behavioral Scale scores -3/-2 (34%) by extracorporeal membrane oxygenation day 3. Median opioid and benzodiazepine doses on the day of cannulation, 0.15 mg/kg/hr (3.7 mg/kg/d) and 0.11 mg/kg/hr (2.8 mg/kg/d), increased by 36% and 58%, respectively, by extracorporeal membrane oxygenation day 3. In the 41 patients successfully decannulated prior to study discharge, patients were receiving 0.40 mg/kg/hr opioids (9.7 mg/kg/d) and 0.39 mg/kg/hr benzodiazepines (9.4 mg/kg/d) at decannulation, an increase from cannulation of 108% and 192%, respectively (both p < 0.001). Extracorporeal membrane oxygenation patients experienced more clinically significant iatrogenic withdrawal than moderate/severe pediatric acute respiratory distress syndrome patients managed without extracorporeal membrane oxygenation support (p < 0.001). Compared to extracorporeal membrane oxygenation patients managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol, usual care extracorporeal membrane oxygenation patients received more opioids during the study period (mean cumulative dose of 183.0 vs 89.8 mg/kg; p = 0.02), over 6.5 greater exposure days (p = 0.002) with no differences in wakefulness or agitation. CONCLUSIONS: In children, the initiation of extracorporeal membrane oxygenation support is associated with deep sedation, substantial sedative exposure, and increased frequency of iatrogenic withdrawal syndrome. A standardized, goal-directed, nurse-driven sedation protocol may help mitigate these effects.
RCT Entities:
OBJECTIVES: To describe sedation management in children supported on extracorporeal membrane oxygenation for acute respiratory failure. DESIGN: Secondary analysis of prospectively collected data from a multicenter randomized trial of sedation (Randomized Evaluation of Sedation Titration for Respiratory Failure). SETTING: Twenty-one U.S. PICUs. PATIENTS: One thousand two hundred fifty-five children, 2 weeks to 17 years old, with moderate/severe pediatric acute respiratory distress syndrome. INTERVENTIONS: Sedation managed per usual care or Randomized Evaluation of Sedation Titration for Respiratory Failure protocol. MEASUREMENTS AND MAIN RESULTS: Sixty-one Randomized Evaluation of Sedation Titration for Respiratory Failurepatients (5%) with moderate/severe pediatric acute respiratory distress syndrome were supported on extracorporeal membrane oxygenation, including 29 managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol. Most extracorporeal membrane oxygenation patients received neuromuscular blockade (46%) or were heavily sedated with State Behavioral Scale scores -3/-2 (34%) by extracorporeal membrane oxygenation day 3. Median opioid and benzodiazepine doses on the day of cannulation, 0.15 mg/kg/hr (3.7 mg/kg/d) and 0.11 mg/kg/hr (2.8 mg/kg/d), increased by 36% and 58%, respectively, by extracorporeal membrane oxygenation day 3. In the 41 patients successfully decannulated prior to study discharge, patients were receiving 0.40 mg/kg/hr opioids (9.7 mg/kg/d) and 0.39 mg/kg/hr benzodiazepines (9.4 mg/kg/d) at decannulation, an increase from cannulation of 108% and 192%, respectively (both p < 0.001). Extracorporeal membrane oxygenation patients experienced more clinically significant iatrogenic withdrawal than moderate/severe pediatric acute respiratory distress syndromepatients managed without extracorporeal membrane oxygenation support (p < 0.001). Compared to extracorporeal membrane oxygenation patients managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol, usual care extracorporeal membrane oxygenation patients received more opioids during the study period (mean cumulative dose of 183.0 vs 89.8 mg/kg; p = 0.02), over 6.5 greater exposure days (p = 0.002) with no differences in wakefulness or agitation. CONCLUSIONS: In children, the initiation of extracorporeal membrane oxygenation support is associated with deep sedation, substantial sedative exposure, and increased frequency of iatrogenic withdrawal syndrome. A standardized, goal-directed, nurse-driven sedation protocol may help mitigate these effects.
Authors: K Shekar; J A Roberts; D V Mullany; A Corley; S Fisquet; T N Bull; A G Barnett; J F Fraser Journal: Anaesth Intensive Care Date: 2012-07 Impact factor: 1.669
Authors: David A Turner; Kyle J Rehder; Desiree Bonadonna; Alice Gray; Shu Lin; David Zaas; Ira M Cheifetz Journal: Pediatrics Date: 2014-08 Impact factor: 7.124
Authors: Marlous J Madderom; Jolanda J C M Reuser; Elisabeth M W J Utens; Joost van Rosmalen; Marlou Raets; Paul Govaert; Katerina Steiner; Saskia J Gischler; Dick Tibboel; Arno F J van Heijst; Hanneke Ijsselstijn Journal: Intensive Care Med Date: 2013-06-06 Impact factor: 17.440
Authors: Stephen Playfor; Ian Jenkins; Carolyne Boyles; Imti Choonara; Gerald Davies; Tim Haywood; Gillian Hinson; Anton Mayer; Neil Morton; Tanya Ralph; Andrew Wolf Journal: Intensive Care Med Date: 2006-05-13 Impact factor: 17.440
Authors: Joseph G Kohne; Graeme MacLaren; Erica Rider; Benjamin D Carr; Palen Mallory; Acham Gebremariam; Matthew L Friedman; Ryan P Barbaro Journal: Pediatr Crit Care Med Date: 2022-01-26 Impact factor: 3.971
Authors: John W Devlin; Hollis R O'Neal; Christopher Thomas; Mary Ann Barnes Daly; Joanna L Stollings; David R Janz; E Wesley Ely; John C Lin Journal: Crit Care Explor Date: 2020-06-12
Authors: Ryan P Barbaro; Yuejia Xu; Santiago Borasino; Edward J Truemper; R Scott Watson; Ravi R Thiagarajan; David Wypij; Martha A Q Curley Journal: Am J Respir Crit Care Med Date: 2018-05-01 Impact factor: 30.528